DK1315505T3 - Farmaceutiske præparater mod hovedpine, migræne, kvalme og emesis - Google Patents

Farmaceutiske præparater mod hovedpine, migræne, kvalme og emesis

Info

Publication number
DK1315505T3
DK1315505T3 DK01965546T DK01965546T DK1315505T3 DK 1315505 T3 DK1315505 T3 DK 1315505T3 DK 01965546 T DK01965546 T DK 01965546T DK 01965546 T DK01965546 T DK 01965546T DK 1315505 T3 DK1315505 T3 DK 1315505T3
Authority
DK
Denmark
Prior art keywords
nausea
emesis
migraine
headache
pharmaceuticals
Prior art date
Application number
DK01965546T
Other languages
English (en)
Inventor
Raphael Barkan
Alexander Mirimsky
Original Assignee
Meditor Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL14463201A external-priority patent/IL144632A0/xx
Application filed by Meditor Pharmaceuticals Ltd filed Critical Meditor Pharmaceuticals Ltd
Application granted granted Critical
Publication of DK1315505T3 publication Critical patent/DK1315505T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Plant Substances (AREA)
DK01965546T 2000-09-05 2001-08-30 Farmaceutiske præparater mod hovedpine, migræne, kvalme og emesis DK1315505T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22981200P 2000-09-05 2000-09-05
IL14463201A IL144632A0 (en) 2001-07-30 2001-07-30 Method and pharmaceutical compositions for treating headache, nausea and migraine
PCT/IL2001/000817 WO2002019961A2 (en) 2000-09-05 2001-08-30 Pharmaceutical compositions for headache, migraine, nausea and emesis

Publications (1)

Publication Number Publication Date
DK1315505T3 true DK1315505T3 (da) 2008-03-03

Family

ID=26324036

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01965546T DK1315505T3 (da) 2000-09-05 2001-08-30 Farmaceutiske præparater mod hovedpine, migræne, kvalme og emesis

Country Status (22)

Country Link
US (2) US7148208B2 (da)
EP (1) EP1315505B1 (da)
JP (1) JP2004508311A (da)
KR (1) KR100849999B1 (da)
CN (1) CN100448439C (da)
AT (1) ATE375797T1 (da)
AU (2) AU2001286178B2 (da)
BR (1) BR0113698A (da)
CA (1) CA2420410C (da)
CY (1) CY1107270T1 (da)
DE (1) DE60131004T2 (da)
DK (1) DK1315505T3 (da)
ES (1) ES2296792T3 (da)
HK (1) HK1058009A1 (da)
HU (1) HUP0302362A3 (da)
IL (1) IL154456A (da)
MD (1) MD2447G2 (da)
MX (1) MXPA03001737A (da)
NO (1) NO20031902L (da)
NZ (1) NZ524903A (da)
PT (1) PT1315505E (da)
WO (1) WO2002019961A2 (da)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0302362A3 (en) * 2000-09-05 2005-05-30 Meditor Pharmaceuticals Ltd Pharmaceutical compositions for headache, migraine, nausea and emesis
US20090186854A1 (en) * 2006-03-23 2009-07-23 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
WO2008152619A1 (en) * 2007-06-13 2008-12-18 Meditor Pharmaceuticals Ltd. Taste masked pharmaceutical compositions of s-alkylisothiouronium derivatives
WO2009060451A2 (en) * 2007-11-06 2009-05-14 Barkan-Farma S.R.L. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
US20100063368A1 (en) * 2008-04-24 2010-03-11 Searete Llc, A Limited Liability Corporation Computational system and method for memory modification
US9449150B2 (en) 2008-04-24 2016-09-20 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US20100130811A1 (en) * 2008-04-24 2010-05-27 Searete Llc Computational system and method for memory modification
US9662391B2 (en) 2008-04-24 2017-05-30 The Invention Science Fund I Llc Side effect ameliorating combination therapeutic products and systems
US9282927B2 (en) 2008-04-24 2016-03-15 Invention Science Fund I, Llc Methods and systems for modifying bioactive agent use
US20100069724A1 (en) * 2008-04-24 2010-03-18 Searete Llc Computational system and method for memory modification
US8930208B2 (en) 2008-04-24 2015-01-06 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US9560967B2 (en) 2008-04-24 2017-02-07 The Invention Science Fund I Llc Systems and apparatus for measuring a bioactive agent effect
US8606592B2 (en) 2008-04-24 2013-12-10 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US8682687B2 (en) 2008-04-24 2014-03-25 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US8876688B2 (en) 2008-04-24 2014-11-04 The Invention Science Fund I, Llc Combination treatment modification methods and systems
US9649469B2 (en) 2008-04-24 2017-05-16 The Invention Science Fund I Llc Methods and systems for presenting a combination treatment
US9064036B2 (en) 2008-04-24 2015-06-23 The Invention Science Fund I, Llc Methods and systems for monitoring bioactive agent use
US8615407B2 (en) 2008-04-24 2013-12-24 The Invention Science Fund I, Llc Methods and systems for detecting a bioactive agent effect
US20090270687A1 (en) * 2008-04-24 2009-10-29 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for modifying bioactive agent use
US9239906B2 (en) 2008-04-24 2016-01-19 The Invention Science Fund I, Llc Combination treatment selection methods and systems
US9026369B2 (en) 2008-04-24 2015-05-05 The Invention Science Fund I, Llc Methods and systems for presenting a combination treatment
US7974787B2 (en) * 2008-04-24 2011-07-05 The Invention Science Fund I, Llc Combination treatment alteration methods and systems
US8357117B2 (en) * 2008-08-06 2013-01-22 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
WO2012018341A1 (en) * 2010-08-05 2012-02-09 Family Health International Device and method for delivering an agent into breast milk while breastfeeding
CN109523244B (zh) * 2018-11-02 2023-06-27 创新先进技术有限公司 一种基于母子账户的用于转移款项数据的方法和系统

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
GB9418912D0 (en) * 1994-09-20 1994-11-09 Fisons Corp Pharmaceutically active compounds
MD263C2 (ro) * 1995-03-01 1995-12-31 Виктор ГИКАВЫЙ Remediu cu acţiune antihipotensivă "IZOTURON"
MD586C2 (ro) * 1995-05-25 1997-03-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Substanţă medicamentoasă cu acţiune antihipotensivă "Difetur"
FR2753098B1 (fr) * 1996-09-06 1998-11-27 Sod Conseils Rech Applic Composition pharmaceutique comprenant au moins un inhibiteur de no synthase et au moins un piegeur des formes reactives de l'oxygene
DK0928191T3 (da) * 1996-09-26 2002-12-30 Meditor Pharmaceuticals Ltd Farmaceutiske præparater indeholdende S-alkylisothiouroniumderivater
WO1998019674A2 (en) * 1996-11-05 1998-05-14 Head Explorer Aps A method for treating tension-type headache
MD1138C2 (ro) * 1997-02-17 1999-07-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Izopropilfosfit-S-izopropilizotiuroniu- substanţă cu acţiune hipertensivă
MD1223C2 (ro) * 1997-07-15 2000-01-31 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Aplicarea dimetilfosfatului de S-metil-izo-tiouroniu în calitate de substanţă vasoconstrictoare şi preparat farmaceutic pe baza lui
US6127420A (en) * 1997-08-22 2000-10-03 The Medical College Of Wisconsin Research Foundation, Inc. L-N5 -(1-imino-3-alkenyl) ornithine and related compounds and use thereof
MD1431G2 (ro) * 1998-01-16 2001-02-28 Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова Remedii antihipotensive
US6093743A (en) * 1998-06-23 2000-07-25 Medinox Inc. Therapeutic methods employing disulfide derivatives of dithiocarbamates and compositions useful therefor
FR2788771B1 (fr) * 1999-01-22 2001-04-13 Pf Medicament Nouvelles 1,2-alcoyl-1-[1-[aryl (alcoyl) oxyalcoyl] piperidin-4-yl]-3-aryl isothiourees substituees, leur preparation et leur application en therapeutique
WO2000051623A2 (en) * 1999-03-05 2000-09-08 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of nitric oxide-induced clinical conditions
CN101850120A (zh) * 1999-07-21 2010-10-06 奥默罗斯公司 用于抑制疼痛,炎症和软骨退化的溶液及方法
HUP0302362A3 (en) * 2000-09-05 2005-05-30 Meditor Pharmaceuticals Ltd Pharmaceutical compositions for headache, migraine, nausea and emesis

Also Published As

Publication number Publication date
BR0113698A (pt) 2003-12-09
MD20020139A (en) 2002-11-30
HUP0302362A3 (en) 2005-05-30
EP1315505A2 (en) 2003-06-04
WO2002019961A3 (en) 2002-08-15
CN1464788A (zh) 2003-12-31
IL154456A (en) 2013-05-30
CA2420410A1 (en) 2002-03-14
AU2001286178B2 (en) 2006-09-14
HK1058009A1 (en) 2004-04-30
EP1315505A4 (en) 2006-02-22
WO2002019961A2 (en) 2002-03-14
CY1107270T1 (el) 2012-11-21
NZ524903A (en) 2004-11-26
HUP0302362A2 (hu) 2003-11-28
US8673979B2 (en) 2014-03-18
CA2420410C (en) 2011-04-26
CN100448439C (zh) 2009-01-07
DE60131004D1 (de) 2007-11-29
NO20031902D0 (no) 2003-04-28
EP1315505B1 (en) 2007-10-17
DE60131004T2 (de) 2008-07-31
AU8617801A (en) 2002-03-22
US7148208B2 (en) 2006-12-12
JP2004508311A (ja) 2004-03-18
KR20030055257A (ko) 2003-07-02
KR100849999B1 (ko) 2008-08-01
MD2447G2 (ro) 2005-12-31
ATE375797T1 (de) 2007-11-15
MD2447F2 (en) 2004-05-31
US20040006044A1 (en) 2004-01-08
ES2296792T3 (es) 2008-05-01
US20070088005A1 (en) 2007-04-19
NO20031902L (no) 2003-06-09
PT1315505E (pt) 2008-01-28
MXPA03001737A (es) 2004-09-10

Similar Documents

Publication Publication Date Title
DK1315505T3 (da) Farmaceutiske præparater mod hovedpine, migræne, kvalme og emesis
TW200503708A (en) Gyrase inhibitors and uses thereof
ZA200701629B (en) Gyrase inhibitors and uses thereof
TW200509924A (en) Compositions of cyclooxygenase-2 selective inhibitors and 5-HT 1B/1D agonists for the treatment and prevention of migraine
NO20050099L (no) 2-ureido-6-heteroaryl-3H-benzoimidazol-4-karboksylsyrederivater og relaterte forbindelser sa som gyrase- og/eller topoisomerase IV-inhibitorer for behandling av bakterielle infeksjoner
NO20075099L (no) Alkynyl-pyrrolopyrmidiner og relaterte analoger som HSP90-inhibitorer
MX2023014274A (es) Compuestos indol sustituidos y metodos de uso de los mismos.
EP1575414A4 (en) METHODS AND DEVICES FOR DETECTION AND THERAPY OF ATHEROMOUS PLAQUES
AU3113902A (en) Thiazolyl inhibitors of tec family tyrosine kinases
MX349137B (es) Metodos y composiciones para el tratamiento de infecciones persistentes y cancer por inhibicion de la ruta de muerte celular programada (pd-1).
WO2002096361A3 (en) 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
WO2006124698A3 (en) Dronabinol treatment of delayed chemotherapy-induced nausea and vomiting
TW200740470A (en) Diclofenac formulations and methods of use
DK1781596T3 (da) Aminosyreafledte profarmaka af propofolsammensætninger og anvendelser deraf
MY138619A (en) N-formyl hydroxylamine compounds
WO2006122123A3 (en) Methods of alleviating disorders and their associated pain
TNSN08451A1 (en) Composition comprising at least one higher aliphatic alcohol and an extract of griffonia simplicifolia
MX2010007543A (es) Inhibidores de iap.
WO2007110047A3 (de) Tergurid/ pr0tergurid zur behandlung vom chronischen schmerzen ( z. b. migräne)
HUP0100964A2 (hu) Gyógyszerészeti kombinációk tramadollal
MXPA05007339A (es) Derivados de alfa-aminoamida utiles como agentes antimigranosos.
MX2022002069A (es) Inhibidores de enzimas.
WO2001060458A3 (en) Inhibitors of prenyl-protein transferase
MX2009008073A (es) Inhibidores de epoxido hidrolasa solubles para el tratamiento de sindrome metabolico y trastornos relacionados.
RS27803A (en) Benzopyran derivatives substituted with secondary amines including tetrazole, method for preparation thereof and pharmaceutical compositions containing them